Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Blueprint Medicines Corp | Director | Common Stock | 13.3K | $1.39M | $105.13 | Jun 12, 2024 | Direct |
Lyell Immunopharma, Inc. | President and CEO, Director | Common Stock | 200K | $456K | $2.28 | Feb 9, 2024 | Direct |
Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 4.57K | $68.6K | $15.01 | Jun 12, 2024 | Direct |
Lyell Immunopharma, Inc. | President and CEO, Director | Stock Option (right to buy) | 0 | Nov 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
LYEL | Lyell Immunopharma, Inc. | Feb 9, 2024 | 1 | $0 | 4 | Feb 13, 2024 | President and CEO, Director |
LYEL | Lyell Immunopharma, Inc. | Nov 16, 2023 | 2 | $0 | 4 | Nov 20, 2023 | President and CEO, Director |
BPMC | Blueprint Medicines Corp | Jun 21, 2023 | 2 | $0 | 4 | Jun 23, 2023 | Director |
LYEL | Lyell Immunopharma, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | President and CEO, Director |
BPMC | Blueprint Medicines Corp | Jun 21, 2022 | 2 | $0 | 4 | Jun 30, 2022 | Director |
LYEL | Lyell Immunopharma, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |
BPMC | Blueprint Medicines Corp | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |